バイオシミラーの世界市場予測(~2021):製品別(組み換え非グリコシル化タンパク質(インスリン、rHGH、インターフェロン)、グリコシル化(mAb、EPO)、ペプチド(グルカゴン、カルシトニン)、製造別、用途別...市場調査レポートについてご紹介

【英文タイトル】Biosimilars Market by Product (Recombinant Non-glycosylated Proteins (Insulin, rHGH, Interferon), glycosylated (mAb, EPO), Peptides (Glucagon, Calcitonin)), Manufacturing (In-House, CMO), Application (Oncology, Blood Disorders) - Global Forecast to 2021

▼当市場調査レポートの詳細内容確認、お問い合わせ及びご購入申込は下記ページでお願いします。▼
バイオシミラーの世界市場予測(~2021):製品別(組み換え非グリコシル化タンパク質(インスリン、rHGH、インターフェロン)、グリコシル化(mAb、EPO)、ペプチド(グルカゴン、カルシトニン)、製造別、用途別 (Code:MAM-BT-2160)

【レポートの概要(一部)】

The global biosimilars market is segmented on the basis of product, manufacturing type, and application. Factors such as rising incidence of various diseases, increasing demand for biosimilar drugs due to their cost-effectiveness, growing pressure to curtail healthcare expenditure, rising geriatric population, strategic collaborations resulting in enhanced productivity and clinical trial activities for biosimilars, and increasing government support and initiatives to develop and promote biosimilars are expected to drive the growth of this market. Emerging markets and new indications and patent expiry of biologic products has opened an array of opportunities for players in the biosimilars market. However, complexities in manufacturing and innovative strategies by biologic drug manufacturers are expected to restrain the growth of this market to a certain extent during the forecast period.
The biosimilars market is expected to reach USD 10.90 Billion by 2021 from USD 3.39 Billion in 2016, at a CAGR of 26.3%.

On the basis of product, the biosimilars market is segmented into recombinant non-glycosylated proteins, recombinant glycosylated proteins, and recombinant peptides. The recombinant non-glycosylated proteins segment is expected to account for the largest share of the market in 2016. Factors such as new product launches, cost-effectiveness, growing incidence of diabetes, and presence of many biosimilar versions of insulin in the pipeline are driving this market.

On the basis of manufacturing type, the biosimilars market is segmented into in-house manufacturing and contract manufacturing organizations. In 2016, the in-house manufacturing segment is expected to account for the largest share of the market. This growth can be attributed to the increasing demand for biosimilar products owing to the rising incidence of various diseases.

On the basis of application, the biosimilars market is segmented into oncology, blood disorders, chronic and autoimmune diseases, growth hormone deficiency, infectious diseases, and other applications. The oncology segment is expected to grow at the highest CAGR during the forecast period.

Based on region, the biosimilars market is segmented into North America, Europe, Asia, and the Rest of the World (RoW). The market is dominated by Europe, followed by Asia, North America, and the Rest of the World (RoW). However, Asia is expected to witness the highest CAGR during the forecast period. This growth can be attributed to factors such as low per capita consumption, rapid growth in economies, rise in technological innovation, trade links, and the rise in medical tourism.

The key players in the biosimilars market include Pfizer Inc. (U.S.), Sandoz International GmbH (Germany), Teva Pharmaceuticals Industries Ltd. (Israel), Amgen Inc. (U.S.), Biocon Ltd. (India), Dr. Reddy’s Laboratories Ltd. (India), F. Hoffmann-La Roche Ltd. (Switzerland), Celltrion Inc. (South Korea), and Samsung Bioepis (South Korea).

.....

【日本語概要(※自動翻訳出力)】

※以下は、Microsoft社の翻訳システムを使用した自動翻訳結果です。レイアウト崩れと不自然な日本語表現が多く表示されます。

。。。(後略)

【レポートの目次(一部)】

1 Introduction (Page No. – 15)
1.1 Objectives of the Study
1.2 Biosimilars Market Definition
1.3 Biosimilars Market Scope
1.3.1 Market Covered
1.3.2 Years Considered for the Study
1.4 Currency
1.5 Limitations
1.6 Stakeholders

2 Research Methodology (Page No. – 18)
2.1 Secondary Data
2.1.1 Key Data From Secondary Sources
2.2 Primary Data
2.2.1 Key Data From Primary Sources
2.3 Biosimilars Market Size Estimation
2.3.1 Bottom-Up Approach
2.3.2 Top-Down Approach
2.4 Biosimilars Market Breakdown & Data Triangulation
2.5 Assumptions for the Study

3 Executive Summary (Page No. – 26)
3.1 Introduction
3.2 Conclusion

4 Premium Insights (Page No. – 30)
4.1 Biosimilars: Market Overview
4.2 Geographic Analysis: Biosimilars Market, By Product
4.3 Biosimilars Market Size, By Application, 2016 vs 2021

5 Market Overview (Page No. – 33)
5.1 Introduction
5.2 Market Dynamics
5.2.1 Drivers
5.2.1.1 Rising Incidences of Diseases
5.2.1.2 Increasing Demand for Biosimilar Drugs Due to Their Cost-Effectiveness
5.2.1.3 Growing Pressure to Curtail Healthcare Expenditure
5.2.1.4 Rising Geriatric Population
5.2.1.5 Strategic Collaborations Resulting in Enhanced Productivity and Clinical Trial Activities for Biosimilars
5.2.1.6 Increasing Government Support and Initiatives to Develop and Promote Biosimilars
5.2.2 Restraints
5.2.2.1 Complexities in Manufacturing and High Costs
5.2.2.2 Innovative Strategies By Biologic Drug Manufacturers
5.2.3 Opportunities
5.2.3.1 Emerging Markets
5.2.3.2 New Indications and Patent Expiry of Biologic Products
5.2.4 Challenge
5.2.4.1 Stringent Regulatory Requirements to Adversely Affect Investments in Biosimilars
5.3 Key Pipeline Products
5.4 Regulatory Outlook
5.4.1 North America
5.4.1.1 U.S.
5.4.1.2 Canada
5.4.2 Europe
5.4.3 Asia
5.4.3.1 China
5.4.3.2 India
5.4.3.3 Japan
5.4.3.4 South Korea
5.4.4 Rest of the World
5.4.4.1 Brazil
5.4.4.2 Mexico
5.4.4.3 Argentina
5.4.4.4 Saudi Arabia
5.5 Biosimilars Services Industry Insights
5.5.1 Introduction
5.5.2 Contract Manufacturing Organizations
5.5.3 Contract Research Organizations
5.5.4 Other Services (Nonclinical & Bioinformatics)

6 Biosimilars Market, By Type of Product (Page No. – 50)
6.1 Introduction
6.2 Recombinant Non-Glycosylated Proteins
6.2.1 Insulin
6.2.2 Recombinant Human Growth Hormone (RHGH)
6.2.3 Granulocyte Colony-Stimulating Factor (Filgrastim)
6.2.4 Interferons
6.3 Recombinant Glycosylated Proteins
6.3.1 Erythropoietin (EPO)
6.3.2 Monoclonal Antibodies (MABS)
6.3.3 Follitropin
6.4 Recombinant Peptides
6.4.1 Glucagon
6.4.2 Calcitonin

7 Biosimilars Market, By Type of Manufacturing (Page No. – 68)
7.1 Introduction
7.2 In-House Manufacturing
7.3 Contract Manufacturing Organizations

8 Biosimilars Market, By Application (Page No. – 72)
8.1 Introduction
8.2 Oncology
8.3 Chronic and Autoimmune Diseases
8.4 Blood Disorders
8.5 Growth Hormone Deficiency
8.6 Infectious Diseases
8.7 Other Applications

9 Biosimilars Market, By Region (Page No. – 81)
9.1 Introduction
9.2 North America Biosimilars Market
9.2.1 U.S.
9.2.2 Canada
9.3 Europe Biosimilars Market
9.3.1 Germany
9.3.2 France
9.3.3 U.K.
9.3.4 Italy
9.3.5 Spain
9.3.6 Rest of Europe
9.4 Asia Biosimilars Market
9.4.1 China
9.4.2 India
9.4.3 Japan
9.4.4 South Korea
9.4.5 Rest of Asia (RoA)
9.5
.....


【日本語目次(※自動翻訳出力)】

※以下は、Microsoft社の翻訳システムを使用した自動翻訳結果です。レイアウト崩れと不自然な日本語表現が多く表示されます。

。。。(後略)

【レポート販売概要】

■ タイトル:バイオシミラーの世界市場予測(~2021):製品別(組み換え非グリコシル化タンパク質(インスリン、rHGH、インターフェロン)、グリコシル化(mAb、EPO)、ペプチド(グルカゴン、カルシトニン)、製造別、用途別
■ 英文:Biosimilars Market by Product (Recombinant Non-glycosylated Proteins (Insulin, rHGH, Interferon), glycosylated (mAb, EPO), Peptides (Glucagon, Calcitonin)), Manufacturing (In-House, CMO), Application (Oncology, Blood Disorders) - Global Forecast to 2021
■ 発行日:2017年1月5日
■ 調査会社:MarketsandMarkets
■ 商品コード:MAM-BT-2160
■ 調査対象地域:グローバル

▼当市場調査レポートの詳細内容確認、お問い合わせ及びご購入申込は下記ページでお願いします。▼
バイオシミラーの世界市場予測(~2021):製品別(組み換え非グリコシル化タンパク質(インスリン、rHGH、インターフェロン)、グリコシル化(mAb、EPO)、ペプチド(グルカゴン、カルシトニン)、製造別、用途別 (Biosimilars Market by Product (Recombinant Non-glycosylated Proteins (Insulin, rHGH, Interferon), glycosylated (mAb, EPO), Peptides (Glucagon, Calcitonin)), Manufacturing (In-House, CMO), Application (Oncology, Blood Disorders) - Global Forecast to 2021 / MAM-BT-2160)

  • 車載エンターテイメントおよび情報システムの世界市場
    About in-vehicle entertainment and information systems Conventional in-vehicle entertainment systems consisted of radio, cassettes, and CDs. The advances in technology and growing demand for personalized entertainment, navigation, and connectivity have redefined these systems. In-vehicle entertainment and information systems are a combination of software and hardware devices installed in automobil …
  • 水晶発振器の世界市場:SPXO、TCXO、VCTCXO、TCVCXO、OCVCXO、FCXO、OCXO、DOCXO、EMXO
    Crystal oscillators are amongst the core components of any electronic device. They use the property of piezoelectricity, which is exhibited by certain crystals, most notably quartz, to create waveforms with accurate frequency based on the mechanical vibration of the precision machined crystal. Crystal oscillator market is triggered due to a lot of factors. The growth of smartphone and tablet marke …
  • 医療産業向けバイオメトリクス(生体認証)の世界市場予測(~2021)
    The healthcare biometrics market is projected to reach USD 2,848.3 Million by 2021 from USD 1,182.6 Million by 2016, at a CAGR of 19.2% during the forecast period. The growth of this market is majorly driven by government initiatives to support the implementation of biometrics in healthcare facilities and increasing healthcare fraud & medical identity theft. On the other hand, the high cost of bio …
  • 米国の末梢血管処置用機器市場見通し(~2021)
    United States Peripheral Vascular Procedures Outlook to 2021 Summary GlobalData’s new report, "United States Peripheral Vascular Procedures Outlook to 2021", provides key procedures data on the United States Peripheral Vascular Procedures. The report provides procedure volumes within market segments - Aortic Open Repair Procedures, Aortic Stent Graft Procedures, Carotid Artery Embolic Protection P …
  • 風力タービン市場規模、技術概要、イシュー、課題
    Wind Turbine - Market Size, Technology Overview, Technology Trends, Issues and Challenges in Turbine Technology Summary Wind turbines have begun to be used for electrical generation, having previously been used for agricultural and grinding purposes. Initial wind turbines had a very small capacity, as well as very low efficiency and performance standards. Wind turbines have gone through various te …
  • 半導体冷却装置の世界市場2016-2020
    About Semiconductor Cooler Semiconductor coolers are TECs used by semiconductor companies. The key vendors in the market include II-VI Marlow Industries, Ferrotec, Liard, TE Technologies, and Komatsu. They are engaged in stiff competition by offering cutting-edge products to consumers in different sectors. Technavio’s analysts forecast the global semiconductor cooler market to grow at a CAGR of 8. …
  • 世界のミサイル及びミサイル防衛システムの市場動向2013-2023:地域別分析
    "The Global Missiles and Missile Defense Systems Market 2013-2023 - Country Analysis: Market Profile" provides details of the key markets in each region, offering an analysis of the top segments of Missiles and Missile Defense Systems, expected to be in demand. It also investigates the top three expected Missiles and Missile Defense Systems programs, in terms of demand in the key markets in each r …
  • リチウムの世界市場
    About LithiumLithium is an alkali metal that is soft, silvery, highly reactive and is used as a heat transfer medium in thermonuclear weapons, batteries, lubricants, various alloys, ceramics, and optical glass. Technavio’s analysts forecast the global lithium market to grow at a CAGR of 8.07% during the period 2017-2021. [Covered in this report] The report covers the present scenario and the growt …
  • キノコの世界市場2016-2020
    Mushrooms are porous, fleshy, and spongy and are most often considered as vegetables. Both individual consumers and foodservice providers are the primary consumers of mushrooms. Consumers globally are willing to pay more for healthy, fresh, and hygienically-packed fresh mushrooms because of their medicinal and nutritional values. Technavio’s analysts forecast the global mushroom market to grow at …
  • UCaaSの世界市場予測
    UCaaS is now becoming an indispensable tool for all forms of business communications, whether it is through video conferencing, teleconference, instant messaging, or by email. UCaaS is now a preferred method of collaboration in organizations. Currently, companies are investing heavily to delivery high quality video, voice, and conferencing collaboration services. Companies in the UC market are loo …
  • Rural Areas Electricity Company S.A.O.C.:発電所及びSWOT分析2013
    Rural Areas Electricity Company S.A.O.C. - Power Plants and SWOT Analysis, 2013 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees (executives), and major products and services. Scope - Major Power Plants (ass …
  • 自動車エアバッグ用インフレータの世界市場2017-2021
    About Automotive Airbag InflatorsAn airbag inflator receives a signal in the event of a vehicle collision and a chemical reaction generates nitrogen gas, which inflates the airbag. Technavio’s analysts forecast the global automotive airbag inflators market to grow at a CAGR of 7.97% during the period 2017-2021. [Covered in this report] The report covers the present scenario and the growth prospect …
  • 高分子ナノコンポジットの世界市場:カーボンナノチューブ、金属酸化物、ナノファイバー、ナノクレイ、グラフェン
    The polymer nanocomposites market size in terms of value is projected to grow at a CAGR of 21-23% between 2015 and 2020 to reach $5,100 million by 2020. Asia-Pacific held the largest share in nanocomposites market in 2014. Major growth in the Asia-Pacific region is expected from the growing packaging, automotive and electronics & semiconductor application. The polymer nanocomposites market in Asia …
  • クローン病(CD)治療薬の世界市場2015-2019
    About CD CD is an ongoing condition that causes inflammation of the digestive tract or the GI tract. CD may also be named as ileitis, granulomatous enteritis or colitis, regional enteritis, or terminal ileitis. The exact etiology of CD is unknown. Usually, CD affects the small intestine and the beginning of the large intestine. However, the disease can disturb any part of the GI tract, from the mo …
  • 世界の次世代癌診断(Cancer Diagnostic)デバイス市場(2012-2016)
    TechNavio's analysts forecast the Global Next-generation Cancer Diagnostic Devices market to grow at a CAGR of 48.11 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increasing prevalence of cancer. The Global Next-generation Cancer Diagnostic Devices market has also been witnessing an increase in mergers and acquisitions among vendors. However, i …
※当サイトは世界の市場調査レポート紹介サイトです。市場規模、市場動向、市場予測など、多様な分析データを含むグローバル調査レポートをご案内致します。日本国内を含むアジア太平洋、中国、ヨーロッパ、アメリカ、北米、中南米、中東、アフリカ地域などにおける、製品、サービス、技術、企業(メーカー、ベンダー)、市場シェア、市場環境など多様な項目に対応致します。当サイトでご紹介するレポートは「市場調査レポート販売サイトのMarketReport.jp」でお問い合わせ及びご購入可能です。